Accumulating debts, brought on by its unsuccessful battle with a former manufacturing partner, have prompted Voxel to file for Chapter 11 bankruptcy. The Laguna Hills, CA, developer of holographic display systems announced on June 2 that it had filed the
Accumulating debts, brought on by its unsuccessful battle with a former manufacturing partner, have prompted Voxel to file for Chapter 11 bankruptcy. The Laguna Hills, CA, developer of holographic display systems announced on June 2 that it had filed the petition to gain protection from creditors while it tries to complete development of its Voxcam imager.
Voxel was on the losing end of a $1.9 million arbitration award in its battle with General Scanning, a Watertown, MA, company that manufactured the first Voxcam imagers until the companies had a falling out over the quality of the systems (SCAN 5/13/98). Voxel did not have a cash reserve to pay the award and was unable to work out a payment schedule with General Scanning. Voxel is also about $2.2 million in debt to bond holders.
In addition to the bankruptcy filing, Voxel has cut its staff to 30 employees, reducing its headcount by 10, according to John Ortega, the firm's controller. Voxel is in negotiations for additional financing to continue operations and would be amenable to an acquisition if it were in the best interests of shareholders, Ortega said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.